Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pfizer Neurontin Neuropathic Pain NDA Planned; Relpax Awaits New Study

Dec 18 2000

• By The Pink Sheet

Related Content

Zeldox and Zyprexa IM formulations

Dec 11 2000

Celebrex, Vioxx GI Safety Data To Be Reviewed By FDA Committee Feb. 7-8

Dec 18 2000

Pfizer Sees Neurontin Exclusivity Through 2002, Pregabalin Filing By Year-End

Jul 31 2000

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window